首页|期刊导航|Clinical Complementary Medicine and Pharmacology|May Traditional Chinese Medicine Reduce the Risk of Developing Rheumatoid Arthritis?An One-armed Prospective Study

May Traditional Chinese Medicine Reduce the Risk of Developing Rheumatoid Arthritis?An One-armed Prospective StudyOA

中文摘要

Background:Rheumatoid arthritis(RA)is a worldwide public health problem.Intervention and prevention before the onset of rheumatic diseases is a new direction in current research.Objective:The aim of this study was to evaluate the potential and feasibility of traditional Chinese medicine(TCM)in the prevention of RA.Methods:This was a single-armed prospective clinical trial.All participants were recruited from a single center in Guangdong,China.Adults who were tested positive for anti-cyclic citrullinated peptide antibody(anti-CCP)and/or rheumatoid factor(RF),had no synovitis and never been treated with disease-modifying anti-rheumatic drugs(DMARDs),were enrolled to take the Huayu-Qiangshen-Tongbi(HQT)decoction orally twice daily,200 mL each time for 24 weeks.Primary outcome was the proportion of patients who met 2010 ACR(American College of Rheumatology)/EULAR(European League Against Rheumatism)classification criteria of RA during observation.Secondary outcomes included levels of anti-CCP,RF,erythrocyte sedimentation rate(ESR),C-reactive protein(CRP),assessment of signs and symptoms,and radiographic progression by magnetic resonance imaging(MRI).Results:19 individuals were enrolled in the study,4 of which withdrew because of the epidemic of COVID-19.During the observation period,3 individuals(20%)developed RA and they had longer morning stiffness(P=0.009)and more obvious synovial enhancement in MRI(P=0.041)at baseline when compared with those who did not develop RA.After 24 weeks of intervention,there were improvements in 28-swollen joint count(SJC28)(P=0.046),Visual Analog Scale(VAS)(P=0.019),Patient’s Global Assessment(PtGA)(P=0.019)and Physician’s Global Assessment(PGA)(P=0.031),but no statistical significance was observed in the levels of anti-CCP,RF,ESR,CRP,morning stiffness,28-tender joint count(TJC28),Health Assessment Questionnaire(HAQ)and magnetic resonance imaging(MRI)analysis(P>0.05).Conclusion:The HQT formula is safe and could improve joint symptoms and signs in these at-risk individuals,but it remains to be investigated in futher study to see if it might potentially reduce the risk of developing RA.Besides,for individuals at high risk to develop RA,morning stiffness and synovial enhancement in MRI might be predictive factors and warning signs.

Kaixin Gao;Qi Liang;Dongyun Li;Chuanning Li;Maojie Wang;Xiumin Chen;Qingchun Huang;Zehuai Wen;Per-Johan Jakobsson;Runyue Huang

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine),Guangzhou 510006,Guangdong,ChinaThe Second Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou 510006,Guangdong,ChinaDepartment of Doctor-Patient Relationship,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,Guangdong,ChinaThe Second Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou 510006,Guangdong,ChinaThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine),Guangzhou 510006,Guangdong,China State Key Laboratory of Dampness Syndrome of Chinese Medicine,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,Guangdong,China Guangdong-Hong Kong-Macao Joint Lab on Chinese Medicine and Immune Disease Research,Guangzhou 510000,Guangdong,ChinaThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine),Guangzhou 510006,Guangdong,China State Key Laboratory of Dampness Syndrome of Chinese Medicine,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,Guangdong,China Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases,Guangzhou 510403,Guangdong,China Guangdong-Hong Kong-Macao Joint Lab on Chinese Medicine and Immune Disease Research,Guangzhou 510000,Guangdong,ChinaThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine),Guangzhou 510006,Guangdong,China State Key Laboratory of Dampness Syndrome of Chinese Medicine,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,Guangdong,China Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases,Guangzhou 510403,Guangdong,China Guangdong-Hong Kong-Macao Joint Lab on Chinese Medicine and Immune Disease Research,Guangzhou 510000,Guangdong,ChinaThe key unit of methodology of clinical research,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510000,Guangdong,ChinaRheumatology Unit,Department of Medicine Solna,Karolinska Institute,Karolinska University Hospital,Stockholm 17177,SwedenThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine),Guangzhou 510006,Guangdong,China State Key Laboratory of Dampness Syndrome of Chinese Medicine,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,Guangdong,China Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases,Guangzhou 510403,Guangdong,China

医药卫生

Rheumatoid arthritis(RA)PreventionTraditional Chinese medicine(TCM)Huayu-Qiangshen-Tongbi decoction(HQT)Clinical trial

《Clinical Complementary Medicine and Pharmacology》 2024 (1)

P.10-18,9

This study was supported by the National Natural Science Foun-dation of China(81804041)the special project of State Key Laboratory of Dampness Syndrome of Chinese Medicine(SZ2020ZZ17)the 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund(The Guangdong-Hong Kong-Macao Joint Lab)(2020B1212030006)Natural Science Foundation of Guang-dong Province(2021A1515011477,2021A1515011593)grant from Guangzhou Basic Research Program(202102010256)the Key Research Project of Guangzhou University of Chinese Medicine(XK2019021)opening project of Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases(2018)(2018B030322012,MB2020KF03),Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine(ZYYCXTD-C-202204)as well as grants from Guangdong Provincial Hospital of Chinese Medicine(MB2019ZZ07,YN10101906,YN2018ML08,YN2018ZD06)。

10.1016/j.ccmp.2023.100127

评论